Emcure Pharmaceuticals share price made a strong debut on the bourses today. On NSE and BSE, Emcure Pharmaceuticals share price opened at ₹1,325.05 per share, 31.45% higher than the issue price of ₹1,008. Market experts anticipated Emcure Pharmaceuticals share price to open in the range of ₹1,370 to ₹1,390 apiece. All sections of the Emcure …
Emcure Pharma IPO: The bidding for the initial public offering (IPO) of Emcure Pharmaceuticals Limited concluded on Friday last week, with the public issue worth ₹1,952.03 crore receiving a robust response from the Indian primary market investors. The Emcure Pharma IPO subscription status reveals that the public issue was oversubscribed 67.87 times in the three …
Emcure Pharmaceuticals IPO subscription status: The market as a whole was strong, and investors responded well to Emcure Pharmaceuticals’ initial public offering (IPO) on the second bidding day today. Non-institutional investors, individual investors, and qualified institutional buyers have all shown interest, which has helped the offering flow rather smoothly. Emcure Pharmaceuticals IPO subscription status was …
Emcure Pharmaceuticals initial public offerings (IPO), which opened for subscription on Wednesday, was fully subscribed by the later half of the first day of bidding, driven by strong demand from non-institutional investors. The issue has been subscribed 1.22 times in the retail category and 1.92 times in the NII portion, on June 3. However, there …
4 min read Last Updated : Jul 03 2024 | 11:44 AM IST Emcure Pharmaceuticals initial public offering is set to open for subscription on Wednesday, July, 3, 2024. The IPO comprises a fresh issue of 7.9 million shares totaling Rs 800.00 crores and an offer for sale of 11.4 million shares amounting to Rs …
Emcure Pharmaceuticals IPO subscription status: The initial public offering of Emcure Pharmaceuticals Ltd has kicked off for subscriptions today (Wednesday, July 3) and has smoothly sailed through its first bidding day, getting fully booked. Emcure Pharma IPO subscription status is 1.32 times, as per BSE data. The quota for non-institutional investors received 2.71 times subscription …
Top news today: On 3 July, a series of events are set to take place right from politics to business. Continuing their unstoppable rally, Indian benchmark indices achieved new historic milestones in early morning trade today. Rohit Sharma posted a special message for Indian fans, inviting them to the victory parade at Mumbai’s Marine Drive. …
The Pune-based Emcure Pharma is all set to launch its initial public offerings (IPO) next week. The IPO will open for subscription on July 3 and will close on July 5. The shares of Emcure Pharma IPO is trading at a premium of ₹255 in the grey market premium (GMP) on Saturday, June 29, just …
Shares of Emcure Pharmaceuticals are trading at a premium of ₹270 in the unlisted market on Saturday (June 29), days ahead of the issue opening for subscription. The grey market is an unofficial ecosystem where shares start trading before the allotment in the IPO and until the listing day. Most investors track the GMP to …
Emcure Pharmaceuticals IPO price band: The Emcure Pharmaceuticals Limited IPO price band has been set in the range of ₹960 to ₹1,008 per equity share of the face value of ₹10. The Emcure Pharmaceuticals IPO date of subscription is scheduled for Wednesday, July 3, and will end on Friday, July 5. The allocation to anchor …